Based upon the molecular interaction between HN and IGFBP-3 and the emerging link between AD and insulin resistance [20], we hypothesized that HN, in addition to its neuroprotective roles, may serve as a centrally-acting regulator of glucose homeostasis. This evidence concerns the gene IGFBP3 and Alzheimer disease.